#hepatocellular carcinoma

Study showed significant improvement in progression-free survival with lenvatinib compared to sorafenib.

Lenvima works as well as standard therapy for metastatic or unresectable cancer.

Twice as many patients were alive 18 months after starting treatment.

Non-alcoholic fatty liver disease can lead to cirrhosis and liver cancer.

Recommendations now include multiple systemic medications in addition to surgery and local therapies.

Study shows VEGF inhibitor is effective for patients with a biomarker of poor prognosis.

Immunotherapy had a low response rate, but most responders continue to do well.

Colorectal, pancreatic and other cancer patient advocates make a strong showing.

Aspirin lowers the risk of several cancers, including liver cancer, stomach cancer and lung cancer.

Alcohol use is linked to higher risk of breast, colon, liver and oral cancers, ASCO says, but the link may not be as scary as it seems.

The median survival exceeded 15 months for patients previously treated with the only approved first-line therapy.

Hepatitis B patients who used aspirin therapy had a 37 percent lower rate of hepatocellular carcinoma.

One of the major international conferences on all aspects of liver disease, opened Sunday in Washington, DC.

With the exception of colon cancer, most cancers associated with overweight or obesity rose over the past decade.

Opdivo will be used to treat hepatocellular carcinoma, which can be caused by hepatitis B or C.